Challenges in genetic diagnosis, co-occurrence of 22q11.2 deletion syndrome and Noonan syndrome.
Josefina ChintonVictoria HuckstadtMaria Eugenia FoncubertaMaria Mercedes PerezMara Cecilia BonettoLuis Pablo GravinaMaría Gabriela ObregonPublished in: American journal of medical genetics. Part A (2022)
Noonan syndrome (NS) is caused by pathogenic variants in genes involved in the RAS/MAPK pathway. On the other hand, 22q11.2 Deletion Syndrome (22q11.2DS) is caused by heterozygous microdeletion on chromosome 22q11.2. The clinical characteristics of both syndromes are expected to be relatively distinct, and, in fact, there is only one report of these syndromes occurring together, but on daily clinical practice and especially in early childhood phenotypes may overlap. In this study, we describe a patient with NS and 22q11.2DS features harboring a heterozygous 2.54 Mb deletion of chromosome 22q11.2 and a variant in LZTR1, c.1531G > A p.(Val511Met). In 1993, Wilson et al reported a patient with both 22q11.2DS and NS, proposing that probably more than one gene is deleted in the proband and that one of the deleted genes is responsible for Noonan's phenotype. In our patient, one of the deleted genes within the 22q11.2 region was the LZTR1 gene which was associated with NS in 2015. This case also highlights the importance of the long-term patients' follow-up to detect evolutionary changes that may appear in the phenotype and alerts clinicians of the co-occurrence of two syndromes that may manifest over time.
Keyphrases
- case report
- genome wide
- copy number
- dengue virus
- genome wide identification
- clinical practice
- end stage renal disease
- early onset
- dna methylation
- signaling pathway
- ejection fraction
- gene expression
- zika virus
- palliative care
- oxidative stress
- tyrosine kinase
- cell proliferation
- transcription factor
- pi k akt
- peritoneal dialysis
- bioinformatics analysis